ALTANA Company Profile

01:34 EST 18th November 2017 | BioPortfolio

ALTANA AG is an international pharmaceuticals and chemicals group with sales of EUR948 million in the first quarter of 2006 and approx. 13,400 employees all over the world. With a return on sales (EBT) of around 20%, ALTANA is one of the most profitable pharmaceuticals and chemicals companies in Europe.
The ALTANA Group is composed of the strategic management holding company, ALTANA AG, and two operating divisions, ALTANA Pharma AG and ALTANA Chemie AG. This structure enhances the flexibility of the individual divisions and enables targeted development.

ALTANA Pharma:
ALTANA Pharma AG, based in Constance, concentrates on innovative prescription therapeutics. Its core business comprises gastrointestinal, respiratory tract, and cardiovascular preparations. In its research, ALTANA Pharma focuses on gastrointestinal (gastroenterology), respiratory tracts (respiration/anti-inflammation), and cancer (oncology). Due to high research and development expenses, intelligent alliances, and the concentration on profitable markets, we have an outstanding position in global competition.

ALTANA Chemie:
ALTANA Chemie AG, headquartered in Wesel, has established itself as a global provider of innovative, environmentally compatible solutions and the corresponding special products for coatings manufacturers, coatings and plastics processors and the electronics industry. The product range includes additives, metallic effect pigments, specialty coatings, sealing and casting compounds, electrical insulation material, impregnating agents as well as testing and measuring instruments. With these products, ALTANA Chemie has been successful in selected niche markets worldwide. All four of its business units are among the leading manufacturers in their markets.


Am Pilgerrain 15
61352 Bad Homburg v. d. Höhe


Phone: +49 (0)6172/ 17 12 -0
Fax: +49 (0)6172/ 17 12 -365

News Articles [5 Associated News Articles listed on BioPortfolio]

2017 Half-Year Results: ALTANA Accelerates Growth Momentum

The specialty chemicals Group ALTANA recorded a pleasing increase in both sales and earnings in the first half of the 2017 fiscal year. Compared to the previous year's period, sales saw a signific...

What’s Next For Nycomed?

Following the acquisition of Altana in 2006, Nycomed grew from a small Scandinavian company into a global pharmaceutical company with the resources to perform its own R&D. Håkan Björklund, CEO, expl...

Global and Asia Copperplate Printing Ink Market Status and Future Forecast 20132023 [Report Updated: 08112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global Dispersants Market 2012 2022 [Report Updated: 01042017] Prices from USD $2400

SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Anionic Type Cationic TypeBased on region, the report de...

Global Copperplate Printing Ink Market Research Report 20112023 [Report Updated: 04112017] Prices from USD $2450

SummaryThe global Copperplate Printing Ink market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of produ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [8 Associated Companies listed on BioPortfolio]


ALTANA AG is an international pharmaceuticals and chemicals group with sales of EUR948 million in the first quarter of 2006 and approx. 13,400 employees all over the world. With a return on sales (EBT...


ALTANA Pharma is a research-based company with dynamic growth. It employs over 8,800 people group-wide at locations in Europe, North and Latin America, South Africa, Asia and Australia. Research and p...

ALTANA Pharma Inc

ALTANA Pharma was launched in Canada in 1997 (as Byk Canada) with just three employees. Today we employ more than 200 people.Find out where it all began and read about where we are today. Learn about...

Altana Incorporated

ALTANA INC. is comprised of three divisions. E. Fougera & Company is a generic drug division which produces mainly topical ointments and creams. It is one of the largest manufacturers and distributor...


ALTANA Inc. is the parent corporation for four New York based divisions of ALTANA Pharma AG: E. Fougera & Company, Savage Laboratories, PharmaDerm and Pharmaderm Animal Health. ALTANA Pharma AG, an in...

More Information about "ALTANA" on BioPortfolio

We have published hundreds of ALTANA news stories on BioPortfolio along with dozens of ALTANA Clinical Trials and PubMed Articles about ALTANA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALTANA Companies in our database. You can also find out about relevant ALTANA Drugs and Medications on this site too.

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record